ZA9810465B - Matrix pellets for greasy oily or sticky drug substances - Google Patents

Matrix pellets for greasy oily or sticky drug substances

Info

Publication number
ZA9810465B
ZA9810465B ZA9810465A ZA9810465A ZA9810465B ZA 9810465 B ZA9810465 B ZA 9810465B ZA 9810465 A ZA9810465 A ZA 9810465A ZA 9810465 A ZA9810465 A ZA 9810465A ZA 9810465 B ZA9810465 B ZA 9810465B
Authority
ZA
South Africa
Prior art keywords
drug substances
matrix pellets
sticky drug
greasy
oily
Prior art date
Application number
ZA9810465A
Other languages
English (en)
Inventor
Christer Karlsson
Per Johan Lundberg
Adam Rosinski
Malin Soederbom
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of ZA9810465B publication Critical patent/ZA9810465B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA9810465A 1997-11-28 1998-11-16 Matrix pellets for greasy oily or sticky drug substances ZA9810465B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9704401A SE9704401D0 (sv) 1997-11-28 1997-11-28 Matrix pellets for greasy, oily or sticky drug substances

Publications (1)

Publication Number Publication Date
ZA9810465B true ZA9810465B (en) 1999-05-21

Family

ID=20409178

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9810465A ZA9810465B (en) 1997-11-28 1998-11-16 Matrix pellets for greasy oily or sticky drug substances

Country Status (23)

Country Link
US (2) US6555138B1 (sv)
EP (1) EP1032371B1 (sv)
JP (1) JP2001524514A (sv)
KR (1) KR20010032558A (sv)
CN (1) CN1280493A (sv)
AR (1) AR016684A1 (sv)
AT (1) ATE286382T1 (sv)
AU (1) AU746324B2 (sv)
BR (1) BR9814756A (sv)
CA (1) CA2311930A1 (sv)
DE (1) DE69828527T2 (sv)
HU (1) HUP0004405A3 (sv)
ID (1) ID24185A (sv)
IL (1) IL136144A0 (sv)
NO (1) NO20002720L (sv)
NZ (1) NZ504354A (sv)
PL (1) PL340926A1 (sv)
RU (1) RU2216316C2 (sv)
SE (1) SE9704401D0 (sv)
SK (1) SK6592000A3 (sv)
TW (1) TW570813B (sv)
WO (1) WO1999027913A1 (sv)
ZA (1) ZA9810465B (sv)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6515009B1 (en) 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5811447A (en) 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
SE9704401D0 (sv) * 1997-11-28 1997-11-28 Astra Ab Matrix pellets for greasy, oily or sticky drug substances
IT1319202B1 (it) 2000-10-12 2003-09-26 Nicox Sa Farmaci per le malattie a base infiammatoria.
US6462021B1 (en) 2000-11-06 2002-10-08 Astrazeneca Ab Use of low molecular weight thrombin inhibitor
AR035216A1 (es) 2000-12-01 2004-05-05 Astrazeneca Ab Derivados de acido mandelico ,derivados farmaceuticamente aceptables, uso de estos derivados para la fabricacion de medicamentos, metodos de tratamiento ,procesos para la preparacion de estos derivados, y compuestos intermediarios
SE0201658D0 (sv) * 2002-05-31 2002-05-31 Astrazeneca Ab Immediate release pharmaceutical formulation
JP3887588B2 (ja) * 2002-08-30 2007-02-28 株式会社リガク Ｘ線回折による応力測定法
US8986737B2 (en) * 2002-09-05 2015-03-24 Wm. Marsh Rice University Antibiotic microspheres for treatment and prevention of osteomyelitis and enhancement of bone regrowth
DK1569912T3 (en) 2002-12-03 2015-06-29 Pharmacyclics Inc 2- (2-hydroxybiphenyl-3-yl) -1h-benzoimidazole-5-carboxamidine derivatives as factor VIIa inhibitors.
US20070059358A1 (en) * 2003-07-02 2007-03-15 Tianjin Tasly Pharmaceutical Co., Ltd., China Matrix adjuvants and the drop pills prepared with them
US20080014228A1 (en) * 2006-07-14 2008-01-17 Olivia Darmuzey Solid form
CA2671728C (en) * 2006-12-20 2015-05-26 Genpharm Ulc Pharmaceutical composition comprising a hot-melt granulated lubricant
AU2014201170B2 (en) * 2006-12-20 2015-09-24 Mylan Pharmaceuticals Ulc Pharmaceutical composition comprising a hot-melt granulated lubricant
US20080311162A1 (en) * 2007-05-16 2008-12-18 Olivia Darmuzey Solid form
BR112016005768B1 (pt) 2013-09-19 2021-09-21 Microvention, Inc Películas de polímero
JP6405369B2 (ja) 2013-09-19 2018-10-17 テルモ株式会社 ポリマー粒子
KR102287781B1 (ko) 2013-11-08 2021-08-06 테루모 가부시키가이샤 중합체 입자
CN104133014B (zh) * 2014-07-16 2015-09-16 广州法尔麦兰药物技术有限公司 一种考察布洛伪麻缓释制剂释放度的方法
US9907880B2 (en) 2015-03-26 2018-03-06 Microvention, Inc. Particles
US10328175B2 (en) 2016-09-28 2019-06-25 Terumo Corporation Polymer particles

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE557670C (de) 1932-08-26 Friedrich Rittershausen Abtast- bzw. Bildzusammensetzvorrichtung
DE454386C (de) 1924-05-27 1928-01-06 Chemische Produkte Vormals H S Verfahren zur Herstellung pharmazeutischer und diaetetischer Praeparate in kugelaehnlicher Form
US2699054A (en) 1953-10-09 1955-01-11 Lloyd H Conover Tetracycline
DE2251197C3 (de) 1972-10-19 1980-05-08 Hoechst Ag, 6000 Frankfurt Verfahren zur Herstellung von hxxochdosierten Tabletten von Tetracyclin- Derivaten
GB8613689D0 (en) * 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
DE3636123A1 (de) * 1986-10-23 1988-05-05 Rentschler Arzneimittel Arzneizubereitungen zur oralen verabreichung, die als einzeldosis 10 bis 240 mg dihydropyridin enthalten
US5051261A (en) * 1987-11-24 1991-09-24 Fmc Corporation Method for preparing a solid sustained release form of a functionally active composition
EP0317780B1 (en) * 1987-11-25 1992-05-20 American Cyanamid Company Sustained (controlled) release delivery system for substituted dihydropyridine calcium channel blockers
US5876754A (en) * 1992-01-17 1999-03-02 Alfatec-Pharma Gmbh Solid bodies containing active substances and a structure consisting of hydrophilic macromolecules, plus a method of producing such bodies
DE59303759C5 (de) * 1992-01-17 2009-04-09 Alfatec-Pharma Gmbh Wirkstoff-enthaltende festkörper mit einem gerüst aus hydrophilen makromolekülen und verfahren zu ihrer herstellung
DE59209690D1 (de) * 1992-02-25 1999-06-10 Spirig Ag Minocyclin enthaltende Pellets
US5431920A (en) * 1993-09-21 1995-07-11 Merck Frosst, Canada, Inc. Enteric coated oral compositions containing bisphosphonic acid antihypercalcemic agents
SE9704401D0 (sv) * 1997-11-28 1997-11-28 Astra Ab Matrix pellets for greasy, oily or sticky drug substances

Also Published As

Publication number Publication date
SK6592000A3 (en) 2001-01-18
EP1032371A1 (en) 2000-09-06
DE69828527D1 (de) 2005-02-10
NO20002720L (no) 2000-07-28
HUP0004405A3 (en) 2004-03-29
IL136144A0 (en) 2001-05-20
AU746324B2 (en) 2002-04-18
ATE286382T1 (de) 2005-01-15
CA2311930A1 (en) 1999-06-10
AR016684A1 (es) 2001-07-25
TW570813B (en) 2004-01-11
US20030175352A1 (en) 2003-09-18
AU1356499A (en) 1999-06-16
SE9704401D0 (sv) 1997-11-28
JP2001524514A (ja) 2001-12-04
BR9814756A (pt) 2000-10-03
HUP0004405A2 (hu) 2001-08-28
DE69828527T2 (de) 2005-12-29
US6555138B1 (en) 2003-04-29
EP1032371B1 (en) 2005-01-05
RU2216316C2 (ru) 2003-11-20
PL340926A1 (en) 2001-03-12
CN1280493A (zh) 2001-01-17
NO20002720D0 (no) 2000-05-26
KR20010032558A (ko) 2001-04-25
NZ504354A (en) 2001-12-21
WO1999027913A1 (en) 1999-06-10
ID24185A (id) 2000-07-13

Similar Documents

Publication Publication Date Title
ZA9810465B (en) Matrix pellets for greasy oily or sticky drug substances
ZA987551B (en) Solid pharmaceutical dosage forms
ZA965190B (en) Pharmaceutical composition.
HUP9800863A3 (en) Drug delivery system for two or more active substances
ZA984379B (en) Gastroretentive controlled release microspheres for improved drug delivery.
ZA982872B (en) Pharmaceutical formulation
ZA985364B (en) Pharmaceutical formulations containing voriconazole.
GB9706089D0 (en) Pharmaceutical composition
DZ2516A1 (fr) Composition pharmaceutique en aérosol.
BR9607752B1 (pt) formulação farmacêutica de microcápsula de liberação controlada.
ZA981029B (en) Pharmaceutical agents.
ZA967546B (en) Pharmaceutical formulation.
ZA968081B (en) Pharmaceutical composition.
IL133928A0 (en) Pharmaceutical composition containing peptichemio
GB9722031D0 (en) Identifiable substances
GB9717444D0 (en) Pharmaceutical composition
HUP0002455A3 (en) Gastric-retained pharmaceutical composition
HK1022853A1 (en) Pharmaceutical compositions.
ZA987392B (en) Pharmaceutical composition.
ZA962268B (en) Pharmaceutical matrix pellets tablets and composition for the preparation thereof
GB9709739D0 (en) Pharmaceutical formulation
ZA987412B (en) 3-Arylsuccinamidohydroxamic acids, processes for their preparation, and drugs containing these substances.
IL122920A (en) Castrointestinal drug composition
EP0987942A4 (en) PHARMACEUTICAL COMPOSITION AND METHOD OF USE
GB9717770D0 (en) Pharmaceutical composition